As younger people like reality TV star Teddi Mellencamp face skin cancer diagnoses, a dermatologist explains why you should be aware of the condition's seriousness.

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

For Melanoma Awareness Month, Dr. Douglas Johnson explains how stage and features of the disease can guide treatment decisions after diagnosis.

At just 26 years old, Leah Adams heard the words no one wants to hear: malignant melanoma. In this powerful and emotional story, Leah shares how a routine skin check—prompted by her mother’s intuition ...

The following is a summary of “Application of interpretable machine learning algorithm to predict lymph node metastasis in cutaneous malignant melanoma,” published in the April 2025 issue of ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on REPL stock prospects.

positivity and a patient's personal risk of melanoma recurrence and/or metastasis. By integrating tumor biology with clinical and pathologic factors using a validated proprietary algorithm ...

this study demonstrates that DecisionDx-Melanoma can identify early-stage CM patients (American Joint Committee on Cancer (AJCC) stage I-II, n=1,661) at higher risk of distant metastasis (DM ...

Melanoma is the most malignant type of skin cancer ... versus dacarbazine for the systemic anti-tumor treatment-naive patients with unresectable or metastatic melanoma. Prior to this, the results of ...

Serious adverse events occurred in 51.2 and 21.9% of patients receiving melphalan/hepatic delivery system and BAC, respectively. HealthDay News — For patients with unresectable metastatic uveal ...